← All investors

Clough Capital Partners

5 portfolio companies · 1 on the map · $957M raised · 1 cities

Portfolio map

1 Clough Capital Partners portfolio company on the map.

Portfolio companies

CRISPR Therapeutics
Boston
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Biotechnology Research$957MEst. 2013

More portfolio companies

4 more Clough Capital Partners investments we track beyond the map.

Portfolio map

1 Clough Capital Partners portfolio company on the map.

Clough Capital Partners portfolio | CleraMap